DENDREON TARGETING CANCER, TRANSFORMING LIVES Trademark
Trademark Overview
On Saturday, October 17, 2020, a trademark application was filed for DENDREON TARGETING CANCER, TRANSFORMING LIVES with the United States Patent and Trademark Office. The USPTO has given the DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark a serial number of 90260940. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2023. This trademark is owned by Dendreon Pharmaceuticals LLC. The DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, immunopharmaceuticals, and vaccines; Research, development, engineering and testing services in the fields of gene therapy, immunopharmaceuticals, and vaccines
General Information
Serial Number | 90260940 |
Word Mark | DENDREON TARGETING CANCER, TRANSFORMING LIVES |
Filing Date | Saturday, October 17, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, January 16, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, April 20, 2021 |
Trademark Statements
Description of Mark | The mark consists of the term "Dendreon" having an upper case "D" and lower case "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e", "o" and "n" the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n" resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case. |
Goods and Services | Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, immunopharmaceuticals, and vaccines; Research, development, engineering and testing services in the fields of gene therapy, immunopharmaceuticals, and vaccines |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 4, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Dendreon Pharmaceuticals LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Seal Beach, CA 90740 |
Party Name | Dendreon Pharmaceuticals LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Seal Beach, CA 90740 |
Trademark Events
Event Date | Event Description |
Wednesday, October 21, 2020 | NEW APPLICATION ENTERED |
Friday, December 4, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, December 5, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, March 8, 2021 | ASSIGNED TO EXAMINER |
Friday, March 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 31, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 20, 2021 | PUBLISHED FOR OPPOSITION |
Tuesday, April 20, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 15, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, December 15, 2021 | SOU TEAS EXTENSION RECEIVED |
Wednesday, December 15, 2021 | SOU EXTENSION 1 FILED |
Wednesday, December 15, 2021 | SOU EXTENSION 1 GRANTED |
Friday, December 17, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, May 4, 2022 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 4, 2022 | SOU EXTENSION 2 FILED |
Wednesday, May 4, 2022 | SOU EXTENSION 2 GRANTED |
Friday, May 6, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, January 16, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, January 17, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Wednesday, December 4, 2024 | WITHDRAWAL OF ATTORNEY GRANTED |
Wednesday, December 4, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |